Both in Pharmaceuticals
Aktis Oncology vs Ardelyx
Over the past year AKTS returned −34.8% and ARDX returned −60.7%; their daily moves had a correlation of 0.16.
AKTS −34.8% ARDX −60.7%Growth of $1, one year, split-adjusted
| Metric | AKTS | ARDX |
|---|---|---|
| Price | $14.61 | $3.05 |
| Market cap | $812.3M | $786.2M |
| Today | +0.10% | +0.49% |
| 1 month | −21.1% | −10.2% |
| 6 months | −24.9% | −57.3% |
| Year to date | — | −47.8% |
| 1 year | — | −49.8% |
| Revenue growth (YoY) | — | +23.8% |
| Gross margin | 100.0% | 95.2% |
| Net margin | −713.5% | −13.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.7× |
| Net cash | $517.3M | $30.0M |
| Dividend yield | — | — |
| Volatility (60d) | 55.1% | 34.2% |
| Short % of float | 18.3% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).